0001209191-22-046711.txt : 20220818 0001209191-22-046711.hdr.sgml : 20220818 20220818173757 ACCESSION NUMBER: 0001209191-22-046711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kulkarni Samarth CENTRAL INDEX KEY: 0001682019 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 221178275 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-16 0 0001674416 CRISPR Therapeutics AG CRSP 0001682019 Kulkarni Samarth C/O CRISPR THERAPEUTICS, INC. 105 W FIRST STREET BOSTON MA 02127 1 1 0 0 Chief Executive Officer Restricted Stock Units 2022-08-16 4 A 0 25000 0.00 A Common Shares 25000 25000 D Performance-based Restricted Stock Units 2022-08-16 4 A 0 150000 0.00 A Common Shares 150000 150000 D Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. The restricted stock units shall vest in full on August 16, 2025, subject to continued service to the Company or any of its subsidiaries. Each performance-based restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Represents the maximum number of shares of CRSP Common Shares that may be awarded upon the achievement of performance conditions. This grant is subject to both time- and performance-based vesting. Performance-based restricted stock units will vest subject to the terms and conditions of the grant agreement evidencing the award and the Company's 2018 Stock Option and Incentive Plan. The performance conditions shall be deemed satisfied subject to achievement of certain share price targets on or before the third anniversary of the date of grant. All of the performance-based restricted stock units that have satisfied the applicable performance-based criteria shall be deemed vested on the third anniversary of the date of grant, subject to continued service to the Company or any of its subsidiaries through such date. /s/ Elizabeth Ryland Waldinger, attorney-in-fact 2022-08-18